NuScale Power Reports Strong Revenue Growth Amid Ongoing Losses in Q1 2025 Earnings Snapshot

NuScale Power Corporation (NYSE: SMR) Q1 2025 Earnings Report Overview

Current Status and Overview:

NuScale Power Corporation is focused on commercializing its Small Modular Reactor (SMR) technology. The company has made substantial progress, having recently received acceptance for its Standard Design Approval (SDA) from the U.S. Nuclear Regulatory Commission (NRC), anticipatable by July 2025.

Key Financial Metrics (Q1 2025 vs. Q1 2024):

• Revenue: $13,375,000 (vs. $1,379,000 in Q1 2024)
• Cost of Sales: $6,373,000 (vs. $735,000)
• Gross Margin: $7,002,000 (vs. $644,000)
• Loss From Operations: $(35,327,000) (vs. $(43,973,000))
• Net Loss: $(30,395,000) (vs. $(48,080,000))
• Loss per Share (Class A): $(0.11) (vs. $(0.21))

Positive Aspects:

• Significant increase in revenue, driven by engineering and licensing services related to the RoPower Nuclear project in Romania.
• Improvement in gross margin, highlighting operational efficiency despite the increase in cost of sales.
• Reduction in losses from operations, indicating effective cost management and operational optimization strategies.
• Notable interest income growth due to bolstered cash resources invested in higher-yielding instruments.

Negative Aspects:

• Net loss remains substantial at $30.4 million, indicating ongoing challenges in achieving profitability.
• High general and administrative expenses ($23,264,000); increased costs associated with strategic business development and transitioning to a larger reporting company.
• Significant accumulated deficit of $391.1 million, which may impact future financing and operational flexibility.
• Dependence on external funding and partnerships for continued growth and project execution.

Cash Flow Highlights:

• Net cash used in operating activities decreased to $(22,786,000) from $(33,489,000), indicating improved cash flow control.
• Net cash provided by financing activities increased significantly to $102,719,000 from $45,214,000, reflecting successful fundraising through stock issuance.
• End of period cash, cash equivalents, and restricted cash totaled $496,522,000, enhancing liquidity position.

Outlook:

NuScale anticipates further development of its SMR technology and continued partnerships with strategic entities like ENTRA1 and Fluor. Despite the significant losses, the company remains committed to transitioning into a commercial enterprise with a focus on securing customer contracts, thus potentially reducing its reliance on funding.

Investors should stay informed of further developments as NuScale continues to navigate complex market conditions while striving for regulatory approvals and operational milestones.